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Indonesia, as part of Asian population, is 
one of the most growing diabetes population 
in the world.1,2 Genetic, aging, urbanization, 
and sedentary lifetstyle are major determinants 
of diabetes in the developing world, include 
Southeast Asia countries.2 They are the causes of 
escalation of diabetes population in Indonesia. 
Increase from time to time, prevalence of 
diabetes mellitus in Indonesia are reaching the 
number over 10% from total adult population.3 
The number of prediabetes subjects are also 
increase from several studies.4
Based on study from latest National Basic 
Health Survey (2013) held by Ministry of Health 
Republic of Indonesia, re-analysed by Idris H 
et al.,3 the prevalence of diabetes mellitus in 
Indonesia is 13%. Idris H et al. used population 
aged above 15th year-old and cut off 126 mg/
dL for fasting blood glucose or 200 mg/dL for 2 
hours post-75 mg oral glucose tolerance test in 
their study. Although used different lower limit 
of age (15th year-old versus 18th year-old) and 
criteria for diabetes from previous study held 
by Pramono LA et al.,5 who re-analysed 2007’s 
National Basic Health Survey, the number 
are increased sharply from 5.6% to 13%. As 
comparison, International Diabetes Federation 
Atlas (IDF) also released data in 2012 which 
stated the prevalence of diabetes in Indonesia 
reached 7.55% with prediabetes prevalence 
reached 12.55%.6
Based on comprehensive review by 
Soewondo P et al.,1 prevalence of diabetes 
mellitus is varies between surveys, study 
locations, and time of studies. Disparities of 
different studies are un-necessarily debated 
while several studies are using different methods 
and diagnosis criterias. One thing for sure, the 
prevalence is growing rapidly and will cause 
national problem since morbidity, mortality, 
and complications are increased and making 
economic burden for national health expenses.7 
Ministry of Health, The Indonesian Society 
of Endocrinology (called as PERKENI), and 
Indonesian Diabetes Association (called as 
PERSADIA) have tried many strategies to 
reduce the burden of late-diagnose and chronic 
complications of diabetes mellitus by screening 
program at primary health care facilities, 
publication of national diabetes guidelines for 
general practitioners and internists, continuing 
medical education for general practitioners, 
internists, endocrinologists, diabetes nurses, 
podiatrists, and diabetes educators.
Despite the hardworks all these years, we 
need systematic and evidence-based prevention 
strategy which can be applied nationally. The 
Diabetes Prevention Program (DPP) Research 
Group in United States, from 1996 to 1999, has 
done large clinical trial which titled The Diabetes 
Prevention Program Clinical Trial, a multicenter 
clinical trial which include 3,234 subjects from 
27 centers who were at high risk for diabetes.8 
This national study formulated DPP lifetstyle 
intervention with 16-sessions core curriculum 
to increase the successful rate of diabetes 
prevention in prediabetes patients.9 The goals 
of intervention are to achieve and maintain at 
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least a 7% weight loss and 700 calories/week 
of physical activity in all lifestyle participants. 
The main result of this clinical trial is decrease 
of type 2 diabetes incidence by 58% in lifestyle 
intervention group compared with 31% in the 
metformin-treated group.8,9
Study from Idris H et al.3 in this issue is a large 
observational study of diabetes prevalence from 
the latest national survey which is very important 
for our database. But, it is more important to 
make programs as a continuation from the study 
to formulate effective and applicative prevention 
programs. We have already known about all risk 
factors studied and correlated significantly in our 
diabetes patients; aging, gender, body mass index, 
blood pressure, lipid profiles, physical inactivity, 
unhealthy diet, and smoking habit.1,3,5 From these 
data, we can make further steps by discussing 
and formulating our own national diabetes 
prevention program clinical trial so we can give 
national recommendation based on the study. 
References from many epidemiology studies 
conducted across Indonesia must be combined 
and systematically appraised to formulate national 
diabetes prevention program clinical trial.
Finland can be a role model which has 
successfully undertaken large-scale of diabetes 
prevention intervention in their country, while 
Australia can be an example of country which 
focuses on scalling up the program in larger 
population.10 We can learn and implement how 
other countries did and success the program. 
Take actions, sustained evaluation, monitoring, 
and scalling up are the key success for diabetes 
prevention program in a national scope.10 
Commitment from government, policy makers, 
clinical leaders, all physicians, and health care 
providers are very important and a key factor for 
the sustainability of diabetes prevention program 
in our society. Right now, the question left is: are 
we ready for Indonesian Diabetes Prevention 
Program?
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